NCT04130230View on ClinicalTrials.gov

Adjuvant Use of Neostigmine in Sepsis and Septic Shock.

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

August 10, 2021

Study Completion Date

October 1, 2021

Conditions
Sepsis, Septic Shock
Interventions
DRUG

Neostigmine

Neostigmine continuous infusion plus standard therapy for sepsis and septic shock.

DRUG

Standard therapy

Standard therapy for sepsis and septic shock

Trial Locations (1)

31527

Tanta University Hospital, Tanta

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04130230 - Adjuvant Use of Neostigmine in Sepsis and Septic Shock. | Biotech Hunter | Biotech Hunter